Quantcast
Channel: WN.com - Articles related to Noven Receives FDA Approval for Brisdelle™ (Paroxetine) Capsules, the First Nonhormonal Therapy for Vasomotor Symptoms Associated with Menopause
Viewing all articles
Browse latest Browse all 189

Menopause hormone use not linked with cognitive problems

$
0
0
By Rachael RettnerPublished June 25, 2013LiveScience Women who start taking hormone replacement therapy in their early 50s do not appear to be at increased risk of cognitive problems later in life, a new study suggests. In the study, menopausal woman ages 50 to 55 who took a common form of hormone replace therapyfor about seven years were no more likely to have cognitive problems in their 60s (such as attention and memory problems) than those who took a...

Viewing all articles
Browse latest Browse all 189

Trending Articles



<script src="https://jsc.adskeeper.com/r/s/rssing.com.1596347.js" async> </script>